Exploring Therapeutic Decisions in Elderly Patients with Non-Small Cell Lung Cancer: Results and Conclusions from North Central Cancer Treatment Group Study N0222
      QxMD      Google Scholar   
Citation:
Cancer Invest vol 29 (4) 266-271
Year:
2011
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
Respiratory
Sec. Committees:
   
Pharmas:
 
Grants:
U10 CA035267, U10 CA052352, U10 CA037417, K24 CA131099, N01 CA035431, CA-37404, CA-35431, 5K24 CA131099, CA-35090, CA-52352, CA-35195, U10 CA037404, U10 CA035448, U10 CA035195, CA-35103, CA-25224, CA-35113, U10 CA035101, U10 CA035113, P30 CA015083, U10 CA035431, CA-37417, CA-35448, CA-35101, U10 CA025224, K24 CA131099-04, U10 CA035090, CA-15083, CA-35267, N01 CA015083, U10 CA035103  
Corr. Author:
 
Authors:
                     
Networks:
 
Study
NCCTG-N0222
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords:
Elderly cancer patients, Non-small cell lung cancer, Carboplatin, Gefitinib